Beclovent, Trimbow(beclomethasone dipropionate)
Beconase, CHF 5993 Chiesi Farmaceutici S.p.A, Qnasl, Qvar, Riarify, Trimbow, Trydonis, Vancenase (beclomethasone dipropionate) is a small molecule pharmaceutical. Beclomethasone dipropionate was first approved as Beclovent on 1982-01-01. It is used to treat allergic rhinitis perennial and inflammation in the USA. It has been approved in Europe to treat chronic obstructive pulmonary disease. It is known to target adhesion G protein-coupled receptor G3.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
Qnasl, Qvar (discontinued: Beclovent, Beconase, Vancenase, Vanceril)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Beclomethasone dipropionate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| QVAR REDIHALER | Norton Waterford | N-207921 RX | 2017-08-03 | 2 products, RLD |
| QNASL | Teva | N-202813 RX | 2012-03-23 | 2 products, RLD, RS |
Show 7 discontinued
Beclomethasone dipropionate monohydrate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| BECONASE AQ | GSK | N-019389 DISCN | 1987-07-27 | 1 products, RLD |
| VANCENASE AQ | Merck & Co | N-019589 DISCN | 1987-12-23 | 1 products |
| VANCENASE AQ | Merck & Co | N-020469 DISCN | 1996-06-26 | 1 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| 5 in 1 clipper spry | OTC monograph not final | 2020-10-16 |
| beconase | New Drug Application | 2021-02-09 |
| beconase aq | New Drug Application | 2009-10-27 |
| beconase aq | 2006-10-06 | |
| qnasl | New Drug Application | 2022-09-27 |
| qvar | New Drug Application | 2018-08-31 |
| qvar redihaler | New Drug Application | 2024-06-25 |
Indications
FDA
EMA
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Beclomethasone Dipropionate, Qvar Redihaler, Norton Waterford | |||
| 11583643 | 2041-08-19 | DP | |
| 11559637 | 2039-07-21 | DP | |
| 10792447 | 2039-01-25 | DP | |
| 11395888 | 2038-01-26 | DP | |
| 11793953 | 2038-01-26 | DP | |
| 11865247 | 2038-01-26 | DP | |
| 8931476 | 2031-07-17 | DP | |
| 8132712 | 2028-09-07 | DP | |
| Beclomethasone Dipropionate, Qvar 40, Teva Branded Pharm | |||
| 10561808 | 2032-01-01 | DP | |
| 9463289 | 2031-05-18 | DP | |
| 9808587 | 2031-05-18 | DP | |
| 10022509 | 2031-05-18 | DP | |
| 10022510 | 2031-05-18 | DP | |
| 10086156 | 2031-05-18 | DP | |
| 10695512 | 2031-05-18 | DP | |
| 11395889 | 2031-05-18 | DP | |
| Beclomethasone Dipropionate, Qnasl, Teva Branded Pharm | |||
| 10188811 | 2031-10-21 | DP | |
| 7780038 | 2027-01-24 | DP | |
ATC Codes
A: Alimentary tract and metabolism drugs
— A07: Antidiarrheals, intestinal antiinflammatory/antiinfective agents
— A07E: Intestinal antiinflammatory agents
— A07EA: Corticosteroids acting locally
— A07EA07: Beclometasone
D: Dermatologicals
— D07: Corticosteroids, dermatological preparations
— D07A: Corticosteroid dermatological preparations, plain
— D07AC: Corticosteroids, potent (group iii)
— D07AC15: Beclometasone
— D07C: Corticosteroids, combinations with antibiotics
— D07CC: Corticosteroids, potent, combinations with antibiotics
— D07CC04: Beclometasone and antibiotics
R: Respiratory system drugs
— R01: Nasal preparations
— R01A: Decongestants and other nasal preparations for topical use
— R01AD: Corticosteroid nasal preparations for topical use
— R01AD01: Beclometasone
— R03: Drugs for obstructive airway diseases
— R03A: Adrenergics, inhalants
— R03AK: Adrenergics inhalants in combination with corticosteroids or other drugs, excl. anticholinergics
— R03AK08: Formoterol and beclometasone
— R03AK13: Salbutamol and beclometasone
— R03AL: Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
— R03AL09: Formoterol, glycopyrronium bromide and beclometasone
— R03B: Other drugs for obstructive airway diseases, inhalants in atc
— R03BA: Glucocorticoid inhalants for obstructive airway disease
— R03BA01: Beclometasone
HCPCS
No data
Clinical
Clinical Trials
243 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Asthma | D001249 | EFO_0000270 | J45 | 6 | 26 | 45 | 23 | 29 | 126 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 7 | 4 | 14 | 10 | 18 | 52 |
| Obstructive lung diseases | D008173 | HP_0006536 | — | 4 | 1 | 12 | 8 | 10 | 35 |
| Lung diseases | D008171 | HP_0002088 | J98.4 | — | 1 | 14 | 7 | 5 | 27 |
| Allergic rhinitis | D065631 | — | J30.9 | 2 | 3 | 12 | 3 | 4 | 23 |
| Rhinitis | D012220 | EFO_0008521 | J31 | 2 | 3 | 12 | 3 | 4 | 23 |
| Allergic rhinitis seasonal | D006255 | EFO_0003956 | J30 | 1 | 3 | 4 | 1 | — | 8 |
| Respiratory sounds | D012135 | HP_0010307 | R06.1 | — | — | 1 | 3 | — | 4 |
| Respiratory tract diseases | D012140 | — | — | — | — | 2 | 1 | — | 3 |
| Respiratory hypersensitivity | D012130 | — | — | — | 1 | 1 | 1 | — | 3 |
Show 19 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Graft vs host disease | D006086 | — | D89.81 | 1 | 4 | 3 | — | 1 | 8 |
| Allergic rhinitis perennial | D012221 | EFO_1001417 | J30.89 | — | — | 6 | — | 2 | 8 |
| Respiratory aspiration | D053120 | EFO_1001839 | — | 1 | — | 1 | — | 1 | 3 |
| Bronchopulmonary dysplasia | D001997 | — | P27.8 | — | 1 | 1 | — | 1 | 3 |
| Sinusitis | D012852 | EFO_0007486 | J32 | — | 1 | 1 | — | — | 2 |
| Bronchiectasis | D001987 | HP_0002110 | J47 | — | — | 1 | — | — | 1 |
| Rhinosinusitis | D000096825 | — | — | — | — | 1 | — | — | 1 |
| Folliculitis | D005499 | — | — | — | 1 | 1 | — | — | 1 |
| Croup | D003440 | EFO_0007227 | J05.0 | — | — | 1 | — | — | 1 |
| Laryngitis | D007827 | — | — | — | — | 1 | — | — | 1 |
Show 1 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Infections | D007239 | EFO_0000544 | — | 1 | 2 | — | — | 3 | 5 |
| Communicable diseases | D003141 | — | — | 1 | 1 | — | — | 3 | 4 |
| Covid-19 | D000086382 | — | — | 1 | 2 | — | — | — | 3 |
| Leukemia | D007938 | — | C95 | 1 | 2 | — | — | — | 2 |
| Myelodysplastic syndromes | D009190 | — | D46 | 1 | 2 | — | — | — | 2 |
| Myeloproliferative disorders | D009196 | — | D47.1 | 1 | 2 | — | — | — | 2 |
| Multiple myeloma | D009101 | — | C90.0 | 1 | 2 | — | — | — | 2 |
| Lymphoma | D008223 | — | C85.9 | 1 | 2 | — | — | — | 2 |
| Plasma cell neoplasms | D054219 | — | — | 1 | 2 | — | — | — | 2 |
| Preleukemia | D011289 | — | — | 1 | 2 | — | — | — | 2 |
Show 65 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hiv | D006678 | — | — | 1 | — | — | — | — | 1 |
| Pharmacokinetics | D010599 | — | — | 1 | — | — | — | — | 1 |
| Eosinophilic esophagitis | D057765 | EFO_0004232 | K20.0 | 1 | — | — | — | — | 1 |
| Esophagitis | D004941 | HP_0100633 | K20 | 1 | — | — | — | — | 1 |
| Respiratory distress syndrome | D012128 | EFO_1000637 | J80 | 1 | — | — | — | — | 1 |
| Acute lung injury | D055371 | EFO_0004610 | — | 1 | — | — | — | — | 1 |
| Newborn respiratory distress syndrome | D012127 | — | P22 | 1 | — | — | — | — | 1 |
| Bronchiolitis | D001988 | HP_0011950 | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Surgical wound infection | D013530 | — | — | — | — | — | — | 2 | 2 |
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | — | — | — | — | 1 | 1 |
| Colitis | D003092 | EFO_0003872 | K52.9 | — | — | — | — | 1 | 1 |
| Ulcer | D014456 | MPATH_579 | — | — | — | — | — | 1 | 1 |
| Smoking | D012907 | EFO_0004318 | — | — | — | — | — | 1 | 1 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 1 | 1 |
| Glaucoma | D005901 | EFO_0000516 | H40 | — | — | — | — | 1 | 1 |
| Intraocular pressure | D007429 | — | — | — | — | — | — | 1 | 1 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | — | 1 | 1 |
| Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | — | — | — | — | 1 | 1 |
Show 11 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Beclomethasone dipropionate |
| INN | beclometasone |
| Description | Beclomethasone dipropionate is a steroid ester comprising beclomethasone having propionyl groups at the 17- and 21-positions. It has a role as an anti-inflammatory drug, an anti-asthmatic drug, a prodrug and an anti-arrhythmia drug. It is a steroid ester, an enone, a 20-oxo steroid, an 11beta-hydroxy steroid, a propanoate ester, a corticosteroid, a glucocorticoid, a 3-oxo-Delta(1),Delta(4)-steroid and a chlorinated steroid. It is functionally related to a beclomethasone. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C |
Identifiers
| PDB | — |
| CAS-ID | 5534-09-8 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1200500 |
| ChEBI ID | 3002 |
| PubChem CID | 21700 |
| DrugBank | DB00394 |
| UNII ID | KGZ1SLC28Z (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
ADGRG3
ADGRG3
Organism
Homo sapiens
Gene name
ADGRG3
Gene synonyms
GPR97, PGR26
NCBI Gene ID
Protein name
adhesion G protein-coupled receptor G3
Protein synonyms
G protein-coupled receptor 97, G-protein coupled receptor 97, G-protein coupled receptor PGR26, probable G-protein coupled receptor 97
Uniprot ID
Mouse ortholog
Adgrg3 (54672)
adhesion G protein-coupled receptor G3 (Q8R0T6)
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Qvar – Teva
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 12,541 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
8,179 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use